Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Other Working Capital Changes (2016 - 2020)

Historic Other Working Capital Changes for Larimar Therapeutics (LRMR) over the last 8 years, with Q4 2020 value amounting to -$193000.0.

  • Larimar Therapeutics' Other Working Capital Changes fell 11184.78% to -$193000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $1.6 million, marking a year-over-year decrease of 4986.3%. This contributed to the annual value of $8.5 million for FY2024, which is 69483.57% up from last year.
  • As of Q4 2020, Larimar Therapeutics' Other Working Capital Changes stood at -$193000.0, which was down 11184.78% from $80000.0 recorded in Q3 2020.
  • Larimar Therapeutics' 5-year Other Working Capital Changes high stood at $1.8 million for Q2 2019, and its period low was -$664000.0 during Q4 2018.
  • Moreover, its 5-year median value for Other Working Capital Changes was $41500.0 (2016), whereas its average is $244450.0.
  • In the last 5 years, Larimar Therapeutics' Other Working Capital Changes tumbled by 263500.0% in 2018 and then surged by 146870.23% in 2019.
  • Quarter analysis of 5 years shows Larimar Therapeutics' Other Working Capital Changes stood at -$157000.0 in 2016, then soared by 49.04% to -$80000.0 in 2017, then crashed by 730.0% to -$664000.0 in 2018, then soared by 345.33% to $1.6 million in 2019, then tumbled by 111.85% to -$193000.0 in 2020.
  • Its Other Working Capital Changes stands at -$193000.0 for Q4 2020, versus $80000.0 for Q3 2020 and $1.7 million for Q2 2020.